He QH et al. |
[The role of superantigen SEB-induced immunotolerance in the immune privileged site]. |
2003 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:15132898
|
Pan ZX et al. |
[IL-18 expression in whole blood cell cultures from active lupus nephritis and the inhibitory effects of FK506, cyclosporin A and dexamethasone]. |
2004 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:15555450
|
Tayama Y et al. |
[Influence of tacrolimus and ciprofloxacin on glucose metabolism]. |
2007 |
Yakugaku Zasshi |
pmid:17978565
|
Naito T |
[Optimal immunosuppressive therapy based on pharmacokinetics and pharmacodynamics of antimetabolites in clinical practice]. |
2010 |
Yakugaku Zasshi |
pmid:21139397
|
Fukudo M |
[Individualized dosage regimen of immunosuppressive drugs based on pharmacokinetic and pharmacodynamic analysis]. |
2007 |
Yakugaku Zasshi |
pmid:17603267
|
Sood S and Muthuraman A |
Activity of tacrolimus: an immunosuppressant, in pyloric ligation-induced peptic ulcer in the rat. |
2009 |
Yakugaku Zasshi |
pmid:19952532
|
Tanaka H et al. |
[Discovery and development of a novel immunosuppressant, tacrolimus hydrate]. |
1997 |
Yakugaku Zasshi |
pmid:9306728
|
Uchida K et al. |
Pharmacokinetics of orally administered tacrolimus in lupus nephritis patients. |
2010 |
Yakugaku Zasshi |
pmid:20046074
|
Niwa T et al. |
Effect of cyclosporine and tacrolimus on cytochrome p450 activities in human liver microsomes. |
2007 |
Yakugaku Zasshi |
pmid:17202802
|
Tanaka Y et al. |
[Effect of tacrolimus on the pharmacokinetics and glucuronidation of SN-38, an active metabolite of irinotecan]. |
2013 |
Yakugaku Zasshi |
pmid:23328499
|